20 results
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Clinically ... Diagnosis and Treatment ... Ho, MD PhD @MatthewHoMD ... #HES #Hematology ... eosinophils #diagnosis #management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... oral antibiotic treatment ... or those with clinical ... #SSTIs #Algorithm
Our approach to the diagnosis and initial management of patients with suspected HIT. Our approach is
laboratory tests, which are ... reevaluate patients in whom ... and to adjust treatment ... #Hematology #HIT ... Thrombocytopenia #Algorithm
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined
Suggested algorithm ... light-chain MGUS in whom ... there are no clinical ... #diagnosis #management ... #hematology #multiplemyeloma
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis
Algorithm for the management of acute bacterial rhinosinusitis.
IDSA Clinical Practice ... Rhinosinusitis Algorithm ... for the management ... - Overall Treatment ... 18 - Overall Harm
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
- Overview Who ... Aplastic Anemia Clinical ... aplastic anemia Treatment ... than 50 years who ... #diagnosis #management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... Guillain-Barre Clinical ... Can begin in arms ... Absent Reflexes: Arms ... #diagnosis #management
Common Variable Immunodeficiency (CVID)

What?
CVID: Immunodeficiency disorder with hypogammaglobulinemia -> increased infection risk secondary to impaired B-cell
Who? ... to 8 years Clinical ... microorganisms or who ... : • Nephrotic syndrome ... (Epstein-Barr syndrome
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... with TB disease who ... Tuberculosis #MDRTB #management ... pharmacology #dosing #idsa
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
acute coronary syndrome ... the treatment goal ... #differential #algorithm ... #management #cardiology ... #treatment #table